nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Gliclazide—VEGFA—ovarian cancer	0.0128	0.75	CrCbGaD
Glimepiride—Chlorpropamide—ABCB1—ovarian cancer	0.00255	0.15	CrCbGaD
Glimepiride—Pruritus—Melphalan—ovarian cancer	0.00177	0.0018	CcSEcCtD
Glimepiride—Tension—Paclitaxel—ovarian cancer	0.00177	0.0018	CcSEcCtD
Glimepiride—Hepatic failure—Doxorubicin—ovarian cancer	0.00176	0.00179	CcSEcCtD
Glimepiride—Hepatitis—Docetaxel—ovarian cancer	0.00175	0.00178	CcSEcCtD
Glimepiride—Hypoglycaemia—Epirubicin—ovarian cancer	0.00175	0.00178	CcSEcCtD
Glimepiride—Nervousness—Paclitaxel—ovarian cancer	0.00175	0.00178	CcSEcCtD
Glimepiride—Diarrhoea—Topotecan—ovarian cancer	0.00175	0.00178	CcSEcCtD
Glimepiride—Cerebrovascular accident—Epirubicin—ovarian cancer	0.00174	0.00177	CcSEcCtD
Glimepiride—Urticaria—Vinorelbine—ovarian cancer	0.00173	0.00176	CcSEcCtD
Glimepiride—Abdominal pain—Vinorelbine—ovarian cancer	0.00173	0.00176	CcSEcCtD
Glimepiride—Glyburide—ABCB1—ovarian cancer	0.00172	0.101	CrCbGaD
Glimepiride—Hyponatraemia—Epirubicin—ovarian cancer	0.00171	0.00174	CcSEcCtD
Glimepiride—Diarrhoea—Melphalan—ovarian cancer	0.00171	0.00174	CcSEcCtD
Glimepiride—Pain in extremity—Epirubicin—ovarian cancer	0.00171	0.00174	CcSEcCtD
Glimepiride—Nausea—Chlorambucil—ovarian cancer	0.0017	0.00173	CcSEcCtD
Glimepiride—Vision blurred—Paclitaxel—ovarian cancer	0.0017	0.00172	CcSEcCtD
Glimepiride—Hot flush—Doxorubicin—ovarian cancer	0.00169	0.00172	CcSEcCtD
Glimepiride—Visual impairment—Docetaxel—ovarian cancer	0.00169	0.00172	CcSEcCtD
Glimepiride—Dizziness—Topotecan—ovarian cancer	0.00169	0.00172	CcSEcCtD
Glimepiride—Tremor—Paclitaxel—ovarian cancer	0.00169	0.00171	CcSEcCtD
Glimepiride—Increased appetite—Doxorubicin—ovarian cancer	0.00168	0.00171	CcSEcCtD
Glimepiride—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00167	0.0017	CcSEcCtD
Glimepiride—Anaemia—Paclitaxel—ovarian cancer	0.00166	0.00169	CcSEcCtD
Glimepiride—Erythema multiforme—Docetaxel—ovarian cancer	0.00166	0.00168	CcSEcCtD
Glimepiride—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00165	0.00168	CcSEcCtD
Glimepiride—Agitation—Paclitaxel—ovarian cancer	0.00165	0.00168	CcSEcCtD
Glimepiride—Angioedema—Paclitaxel—ovarian cancer	0.00164	0.00167	CcSEcCtD
Glimepiride—Vomiting—Topotecan—ovarian cancer	0.00162	0.00165	CcSEcCtD
Glimepiride—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00162	0.00165	CcSEcCtD
Glimepiride—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00161	0.00164	CcSEcCtD
Glimepiride—Leukopenia—Paclitaxel—ovarian cancer	0.00161	0.00164	CcSEcCtD
Glimepiride—Rash—Topotecan—ovarian cancer	0.00161	0.00164	CcSEcCtD
Glimepiride—Hypersensitivity—Vinorelbine—ovarian cancer	0.00161	0.00164	CcSEcCtD
Glimepiride—Dermatitis—Topotecan—ovarian cancer	0.00161	0.00164	CcSEcCtD
Glimepiride—Headache—Topotecan—ovarian cancer	0.0016	0.00163	CcSEcCtD
Glimepiride—Palpitations—Paclitaxel—ovarian cancer	0.00159	0.00162	CcSEcCtD
Glimepiride—Vomiting—Melphalan—ovarian cancer	0.00159	0.00162	CcSEcCtD
Glimepiride—Hyponatraemia—Doxorubicin—ovarian cancer	0.00159	0.00161	CcSEcCtD
Glimepiride—Loss of consciousness—Paclitaxel—ovarian cancer	0.00158	0.00161	CcSEcCtD
Glimepiride—Pain in extremity—Doxorubicin—ovarian cancer	0.00158	0.00161	CcSEcCtD
Glimepiride—Rash—Melphalan—ovarian cancer	0.00158	0.0016	CcSEcCtD
Glimepiride—Dermatitis—Melphalan—ovarian cancer	0.00157	0.0016	CcSEcCtD
Glimepiride—Asthenia—Vinorelbine—ovarian cancer	0.00157	0.00159	CcSEcCtD
Glimepiride—Arrhythmia—Docetaxel—ovarian cancer	0.00156	0.00159	CcSEcCtD
Glimepiride—Convulsion—Paclitaxel—ovarian cancer	0.00156	0.00159	CcSEcCtD
Glimepiride—Hypertension—Paclitaxel—ovarian cancer	0.00155	0.00158	CcSEcCtD
Glimepiride—Pruritus—Vinorelbine—ovarian cancer	0.00154	0.00157	CcSEcCtD
Glimepiride—Anxiety—Paclitaxel—ovarian cancer	0.00153	0.00155	CcSEcCtD
Glimepiride—Malnutrition—Docetaxel—ovarian cancer	0.00152	0.00155	CcSEcCtD
Glimepiride—Erythema—Docetaxel—ovarian cancer	0.00152	0.00155	CcSEcCtD
Glimepiride—Nausea—Topotecan—ovarian cancer	0.00152	0.00154	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00151	0.00153	CcSEcCtD
Glimepiride—Dry mouth—Paclitaxel—ovarian cancer	0.0015	0.00152	CcSEcCtD
Glimepiride—Diarrhoea—Vinorelbine—ovarian cancer	0.00149	0.00152	CcSEcCtD
Glimepiride—Abdominal distension—Epirubicin—ovarian cancer	0.00149	0.00151	CcSEcCtD
Glimepiride—Nausea—Melphalan—ovarian cancer	0.00148	0.00151	CcSEcCtD
Glimepiride—Confusional state—Paclitaxel—ovarian cancer	0.00148	0.00151	CcSEcCtD
Glimepiride—Influenza—Epirubicin—ovarian cancer	0.00148	0.0015	CcSEcCtD
Glimepiride—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00147	0.00149	CcSEcCtD
Glimepiride—Eosinophilia—Epirubicin—ovarian cancer	0.00146	0.00149	CcSEcCtD
Glimepiride—Shock—Paclitaxel—ovarian cancer	0.00144	0.00147	CcSEcCtD
Glimepiride—Dizziness—Vinorelbine—ovarian cancer	0.00144	0.00147	CcSEcCtD
Glimepiride—Angina pectoris—Epirubicin—ovarian cancer	0.00144	0.00146	CcSEcCtD
Glimepiride—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00144	0.00146	CcSEcCtD
Glimepiride—Tachycardia—Paclitaxel—ovarian cancer	0.00143	0.00146	CcSEcCtD
Glimepiride—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00142	0.00144	CcSEcCtD
Glimepiride—Anaemia—Docetaxel—ovarian cancer	0.00141	0.00143	CcSEcCtD
Glimepiride—Pancytopenia—Epirubicin—ovarian cancer	0.0014	0.00143	CcSEcCtD
Glimepiride—Anorexia—Paclitaxel—ovarian cancer	0.0014	0.00142	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00139	0.00142	CcSEcCtD
Glimepiride—Vomiting—Vinorelbine—ovarian cancer	0.00139	0.00141	CcSEcCtD
Glimepiride—Rash—Vinorelbine—ovarian cancer	0.00138	0.0014	CcSEcCtD
Glimepiride—Dermatitis—Vinorelbine—ovarian cancer	0.00137	0.0014	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—ovarian cancer	0.00137	0.0014	CcSEcCtD
Glimepiride—Hypotension—Paclitaxel—ovarian cancer	0.00137	0.0014	CcSEcCtD
Glimepiride—Headache—Vinorelbine—ovarian cancer	0.00137	0.00139	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—ovarian cancer	0.00137	0.00139	CcSEcCtD
Glimepiride—Leukopenia—Docetaxel—ovarian cancer	0.00136	0.00139	CcSEcCtD
Glimepiride—Pollakiuria—Epirubicin—ovarian cancer	0.00136	0.00139	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—ovarian cancer	0.00135	0.00138	CcSEcCtD
Glimepiride—Palpitations—Docetaxel—ovarian cancer	0.00135	0.00137	CcSEcCtD
Glimepiride—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00135	0.00137	CcSEcCtD
Glimepiride—Weight increased—Epirubicin—ovarian cancer	0.00134	0.00137	CcSEcCtD
Glimepiride—Loss of consciousness—Docetaxel—ovarian cancer	0.00134	0.00136	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—ovarian cancer	0.00133	0.00135	CcSEcCtD
Glimepiride—Insomnia—Paclitaxel—ovarian cancer	0.00133	0.00135	CcSEcCtD
Glimepiride—Convulsion—Docetaxel—ovarian cancer	0.00132	0.00134	CcSEcCtD
Glimepiride—Paraesthesia—Paclitaxel—ovarian cancer	0.00132	0.00134	CcSEcCtD
Glimepiride—Hypertension—Docetaxel—ovarian cancer	0.00132	0.00134	CcSEcCtD
Glimepiride—Drowsiness—Epirubicin—ovarian cancer	0.00132	0.00134	CcSEcCtD
Glimepiride—Dyspnoea—Paclitaxel—ovarian cancer	0.00131	0.00133	CcSEcCtD
Glimepiride—Somnolence—Paclitaxel—ovarian cancer	0.00131	0.00133	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.0013	0.00133	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—ovarian cancer	0.0013	0.00132	CcSEcCtD
Glimepiride—Nausea—Vinorelbine—ovarian cancer	0.0013	0.00132	CcSEcCtD
Glimepiride—Dyspepsia—Paclitaxel—ovarian cancer	0.00129	0.00131	CcSEcCtD
Glimepiride—Jaundice—Epirubicin—ovarian cancer	0.00128	0.0013	CcSEcCtD
Glimepiride—Decreased appetite—Paclitaxel—ovarian cancer	0.00128	0.0013	CcSEcCtD
Glimepiride—Dry mouth—Docetaxel—ovarian cancer	0.00127	0.00129	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00127	0.00129	CcSEcCtD
Glimepiride—Fatigue—Paclitaxel—ovarian cancer	0.00127	0.00129	CcSEcCtD
Glimepiride—Sweating—Epirubicin—ovarian cancer	0.00126	0.00128	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—ovarian cancer	0.00126	0.00128	CcSEcCtD
Glimepiride—Confusional state—Docetaxel—ovarian cancer	0.00125	0.00128	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00125	0.00127	CcSEcCtD
Glimepiride—Anaphylactic shock—Docetaxel—ovarian cancer	0.00124	0.00127	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—ovarian cancer	0.00124	0.00126	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—ovarian cancer	0.00123	0.00125	CcSEcCtD
Glimepiride—Shock—Docetaxel—ovarian cancer	0.00122	0.00125	CcSEcCtD
Glimepiride—Thrombocytopenia—Docetaxel—ovarian cancer	0.00122	0.00124	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—ovarian cancer	0.00122	0.00124	CcSEcCtD
Glimepiride—Tachycardia—Docetaxel—ovarian cancer	0.00121	0.00124	CcSEcCtD
Glimepiride—Feeling abnormal—Paclitaxel—ovarian cancer	0.00121	0.00123	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00121	0.00123	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—ovarian cancer	0.0012	0.00122	CcSEcCtD
Glimepiride—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.0012	0.00122	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—ovarian cancer	0.00119	0.00121	CcSEcCtD
Glimepiride—Anorexia—Docetaxel—ovarian cancer	0.00119	0.00121	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—ovarian cancer	0.00118	0.0012	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—ovarian cancer	0.00117	0.00119	CcSEcCtD
Glimepiride—Urticaria—Paclitaxel—ovarian cancer	0.00117	0.00119	CcSEcCtD
Glimepiride—Hypotension—Docetaxel—ovarian cancer	0.00116	0.00118	CcSEcCtD
Glimepiride—Abdominal pain—Paclitaxel—ovarian cancer	0.00116	0.00118	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—ovarian cancer	0.00114	0.00116	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—ovarian cancer	0.00114	0.00116	CcSEcCtD
Glimepiride—Insomnia—Docetaxel—ovarian cancer	0.00113	0.00114	CcSEcCtD
Glimepiride—Paraesthesia—Docetaxel—ovarian cancer	0.00112	0.00114	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—ovarian cancer	0.00112	0.00114	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—ovarian cancer	0.00111	0.00113	CcSEcCtD
Glimepiride—Dyspnoea—Docetaxel—ovarian cancer	0.00111	0.00113	CcSEcCtD
Glimepiride—Somnolence—Docetaxel—ovarian cancer	0.00111	0.00113	CcSEcCtD
Glimepiride—Dyspepsia—Docetaxel—ovarian cancer	0.0011	0.00111	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—ovarian cancer	0.00109	0.00111	CcSEcCtD
Glimepiride—Decreased appetite—Docetaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Glimepiride—Hypersensitivity—Paclitaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00107	0.00109	CcSEcCtD
Glimepiride—Fatigue—Docetaxel—ovarian cancer	0.00107	0.00109	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—ovarian cancer	0.00106	0.00107	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—ovarian cancer	0.00105	0.00107	CcSEcCtD
Glimepiride—Asthenia—Paclitaxel—ovarian cancer	0.00105	0.00107	CcSEcCtD
Glimepiride—Pruritus—Paclitaxel—ovarian cancer	0.00104	0.00106	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—ovarian cancer	0.00103	0.00105	CcSEcCtD
Glimepiride—Erythema—Epirubicin—ovarian cancer	0.00103	0.00105	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—ovarian cancer	0.00103	0.00105	CcSEcCtD
Glimepiride—Feeling abnormal—Docetaxel—ovarian cancer	0.00103	0.00104	CcSEcCtD
Glimepiride—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00102	0.00104	CcSEcCtD
Glimepiride—Tension—Epirubicin—ovarian cancer	0.00101	0.00103	CcSEcCtD
Glimepiride—Diarrhoea—Paclitaxel—ovarian cancer	0.001	0.00102	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—ovarian cancer	0.000999	0.00102	CcSEcCtD
Glimepiride—Abdominal pain—Docetaxel—ovarian cancer	0.000984	0.001	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—ovarian cancer	0.000976	0.000993	CcSEcCtD
Glimepiride—Dizziness—Paclitaxel—ovarian cancer	0.000971	0.000988	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—ovarian cancer	0.000969	0.000986	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—ovarian cancer	0.000951	0.000968	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—ovarian cancer	0.000951	0.000968	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—ovarian cancer	0.00095	0.000967	CcSEcCtD
Glimepiride—Agitation—Epirubicin—ovarian cancer	0.000945	0.000961	CcSEcCtD
Glimepiride—Tension—Doxorubicin—ovarian cancer	0.000934	0.00095	CcSEcCtD
Glimepiride—Vomiting—Paclitaxel—ovarian cancer	0.000933	0.00095	CcSEcCtD
Glimepiride—Rash—Paclitaxel—ovarian cancer	0.000926	0.000942	CcSEcCtD
Glimepiride—Dermatitis—Paclitaxel—ovarian cancer	0.000925	0.000941	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—ovarian cancer	0.000924	0.00094	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—ovarian cancer	0.00092	0.000936	CcSEcCtD
Glimepiride—Headache—Paclitaxel—ovarian cancer	0.00092	0.000936	CcSEcCtD
Glimepiride—Hypersensitivity—Docetaxel—ovarian cancer	0.000917	0.000933	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—ovarian cancer	0.000909	0.000925	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—ovarian cancer	0.000904	0.00092	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—ovarian cancer	0.000897	0.000912	CcSEcCtD
Glimepiride—Asthenia—Docetaxel—ovarian cancer	0.000893	0.000908	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—ovarian cancer	0.000891	0.000906	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—ovarian cancer	0.000888	0.000903	CcSEcCtD
Glimepiride—Pruritus—Docetaxel—ovarian cancer	0.00088	0.000896	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—ovarian cancer	0.000879	0.000895	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—ovarian cancer	0.000874	0.00089	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—ovarian cancer	0.000872	0.000888	CcSEcCtD
Glimepiride—Nausea—Paclitaxel—ovarian cancer	0.000872	0.000887	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—ovarian cancer	0.000856	0.000871	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—ovarian cancer	0.000852	0.000866	CcSEcCtD
Glimepiride—Diarrhoea—Docetaxel—ovarian cancer	0.000851	0.000866	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—ovarian cancer	0.000846	0.000861	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—ovarian cancer	0.000841	0.000855	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—ovarian cancer	0.000839	0.000854	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—ovarian cancer	0.000836	0.000851	CcSEcCtD
Glimepiride—Shock—Epirubicin—ovarian cancer	0.000826	0.00084	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—ovarian cancer	0.000824	0.000839	CcSEcCtD
Glimepiride—Dizziness—Docetaxel—ovarian cancer	0.000823	0.000837	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—ovarian cancer	0.000822	0.000836	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—ovarian cancer	0.000821	0.000836	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—ovarian cancer	0.000819	0.000833	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—ovarian cancer	0.000811	0.000825	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—ovarian cancer	0.000807	0.000821	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—ovarian cancer	0.0008	0.000814	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—ovarian cancer	0.000792	0.000806	CcSEcCtD
Glimepiride—Vomiting—Docetaxel—ovarian cancer	0.000791	0.000805	CcSEcCtD
Glimepiride—Rash—Docetaxel—ovarian cancer	0.000785	0.000798	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—ovarian cancer	0.000784	0.000798	CcSEcCtD
Glimepiride—Dermatitis—Docetaxel—ovarian cancer	0.000784	0.000797	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—ovarian cancer	0.000783	0.000797	CcSEcCtD
Glimepiride—Headache—Docetaxel—ovarian cancer	0.000779	0.000793	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000777	0.00079	CcSEcCtD
Glimepiride—Shock—Doxorubicin—ovarian cancer	0.000764	0.000777	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00076	0.000774	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—ovarian cancer	0.000759	0.000772	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—ovarian cancer	0.000758	0.000771	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—ovarian cancer	0.000754	0.000767	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000751	0.000764	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—ovarian cancer	0.000748	0.000761	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—ovarian cancer	0.000746	0.000759	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—ovarian cancer	0.00074	0.000753	CcSEcCtD
Glimepiride—Nausea—Docetaxel—ovarian cancer	0.000739	0.000752	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—ovarian cancer	0.000739	0.000752	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—ovarian cancer	0.00073	0.000742	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—ovarian cancer	0.000726	0.000738	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000725	0.000737	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—ovarian cancer	0.000724	0.000736	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—ovarian cancer	0.000702	0.000715	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—ovarian cancer	0.000697	0.000709	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—ovarian cancer	0.000692	0.000704	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—ovarian cancer	0.000692	0.000704	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—ovarian cancer	0.00069	0.000702	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000686	0.000698	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—ovarian cancer	0.000684	0.000695	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—ovarian cancer	0.000675	0.000687	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00067	0.000682	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—ovarian cancer	0.00067	0.000681	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—ovarian cancer	0.000667	0.000678	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—ovarian cancer	0.000663	0.000675	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—ovarian cancer	0.00064	0.000651	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000635	0.000646	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—ovarian cancer	0.000618	0.000629	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—ovarian cancer	0.000617	0.000628	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—ovarian cancer	0.000614	0.000625	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—ovarian cancer	0.000602	0.000613	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—ovarian cancer	0.000594	0.000604	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—ovarian cancer	0.000574	0.000584	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—ovarian cancer	0.000572	0.000582	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—ovarian cancer	0.000557	0.000567	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—ovarian cancer	0.000555	0.000565	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—ovarian cancer	0.000549	0.000559	CcSEcCtD
Glimepiride—Vomiting—Epirubicin—ovarian cancer	0.000534	0.000543	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—ovarian cancer	0.000531	0.000541	CcSEcCtD
Glimepiride—Rash—Epirubicin—ovarian cancer	0.000529	0.000538	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—ovarian cancer	0.000529	0.000538	CcSEcCtD
Glimepiride—Headache—Epirubicin—ovarian cancer	0.000526	0.000535	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—ovarian cancer	0.000514	0.000522	CcSEcCtD
Glimepiride—Nausea—Epirubicin—ovarian cancer	0.000499	0.000507	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—ovarian cancer	0.000494	0.000502	CcSEcCtD
Glimepiride—Rash—Doxorubicin—ovarian cancer	0.00049	0.000498	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—ovarian cancer	0.000489	0.000498	CcSEcCtD
Glimepiride—Headache—Doxorubicin—ovarian cancer	0.000486	0.000495	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—ovarian cancer	0.000461	0.000469	CcSEcCtD
